Table 1.

Clinical and demographic information of cancer patients and healthy controls.

	Cancer T: n=65	Healthy T: n=69	Total T: n=134	P-value (cancer/healthy)
	S: n= 25	S: n=27	S: n=52
Age years, mean [SD]	T: 56.1 [13.4] S: 57.5 [9.9]	T: 59.3 [7.8] S: 60.1 [9.9]	T: 57.9 [11] S: 58.5 [10.0]	T: 0.08 (Unpaired T-test) S: 0.09 (Unpaired T-test)
BMI, mean [SD]	T: 31.4 [7.6] S: 29.1 [7.7]	T: 28.7 [7.9] S: 29.4 [7.4]	T: 30.1 [7.8] S: 29.1 [7.6]	T: 0.02 (Kruskal-Wallis) S: 0.02 (Kruskal-Wallis)
Self-reported race, n (%)
Caucasian	T: 29 (44.6%) T: 14 (56.0%)	T: 31 (44.9%) T: 17 (63.0%)	T: 60 (44.8%) T: 31 (59.6%)	T: 0.51 (Fisher-exact) S: 0.57 (Fisher-exact)
African American	T: 34 (52.3%) T: 10 (40.0%)	T: 33 (47.8%) T: 9 (33.3%)	T: 67 (50.0%) T: 19 (36.5%)
Asian	T: 2 (3.1%) T: 1 (4.0%)	T: 5 (7.2%) T: 1 (3.7%)	T: 7 (5.2%) T: 2 (3.8%)
Diagnosis, n (%)
Endometrial	T: 36 (55.4%) S: 14 (56.0%)
Cervical	T: 29 (44.6%) S: 11 (44.0%)
Type of Treatment at T0	T: n=65 | S: n=25
Surgery	T: 30 (46%) | T: 13 (52%)
Surgery + Chemotherapy	T: 7 (11%) | T: 3 (12%)
None	T: 18 (27%) | T: 9 (36%)
Type of Treatment at T1	S: n=25
Radiation	11 (44%)
Radiation + Chemotherapy	14 (66%)
None	0 (0%)

Table depicts all subjects included in the study. After quality assurance, a total of six datasets were excluded due to low quality, thus 124 subjects had VM at T0. For a subset of those subjects (n=52), longitudinal data were obtained (depicted in grey color). After excluding low quality datasets, 42 subjects (22 cancer and 20 healthy) had longitudinal VM data at four time points.

Summary statistics are given for the total population recruited in the study and had baseline data analyzed (T) as well as for the subset of patients that had longitudinal data available (S).